Glucocorticoids inhibit cytokine-mediated eosinophil survival

Area of Science:

• Immunology
• Pharmacology

Background:

• Glucocorticoids are known to cause eosinopenia and treat eosinophilic disorders.
• The in vitro effect of glucocorticoids on eosinophil survival, particularly in response to cytokines, requires further elucidation.

Purpose of the Study:

• To investigate the direct impact of glucocorticoids on the survival of human eosinophils in vitro.
• To determine how glucocorticoids modulate cytokine-driven eosinophil survival and explore potential mechanisms of resistance.

Main Methods:

• Human eosinophils were isolated and cultured with various cytokines (IL-5, GM-CSF, IL-3, IFN-gamma) and glucocorticoids (dexamethasone, methylprednisolone, hydrocortisone).
• Cell viability was assessed using fluorescein diacetate and propidium iodide staining.
• Dose- and time-dependency of glucocorticoid effects and cytokine antagonism were analyzed.

Main Results:

• Glucocorticoids (dexamethasone, methylprednisolone, hydrocortisone) significantly inhibited eosinophil survival in a dose- and time-dependent manner.
• Cytokines like IL-5, GM-CSF, and IL-3 enhanced eosinophil survival, but their effects were inhibited by dexamethasone.
• Higher concentrations of IL-5, GM-CSF, and IL-3 could partially or fully reverse dexamethasone's inhibitory effect, while IFN-gamma's effect was not overcome.

Conclusions:

• Glucocorticoids exert a direct inhibitory effect on human eosinophil survival, contributing to their therapeutic efficacy in eosinophilic diseases.
• Cytokine antagonism of this effect, particularly by IL-5, GM-CSF, and IL-3, may represent a mechanism underlying glucocorticoid resistance.